Gary Jay Sternberg
Technik-/Wissenschafts-/F&E-Leiter bei AERIE PHARMACEUTICALS, INC.
Ursprung des Netzwerks ersten Grades von Gary Jay Sternberg
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 37 | |
Extinct | Pharmaceuticals: Major | 19 | |
Stargazer Pharmaceuticals, Inc.
Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA.
5
| Holding Company | Pharmaceuticals: Major | 5 |
RainBio, Inc.
RainBio, Inc. BiotechnologyHealth Technology Part of CalciMedica, Inc., RainBio, Inc. is a gene therapy company based in Raleigh, NC. RainBio, Inc. focuses on developing novel, sight-saving treatments for blinding corneal diseases. RainBio's lead program, RBIO-1, targets corneal blindness in mucopolysaccharidosis I (MPS I), a rare genetic disorder in children. Gary Jay Sternberg has been the CEO of the company since October 12, 2021. RainBio was acquired by Graybug Vision, Inc. on May 10, 2022.
4
| Subsidiary | Biotechnology | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Gary Jay Sternberg
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ALCON INC. | Medical Specialties | Director of Finance/CFO Chief Executive Officer Director of Finance/CFO General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
ALLERGAN, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Biotechnology | Chief Executive Officer Chairman Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Director/Board Member Doctorate Degree Doctorate Degree | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal | |
CLEARSIDE BIOMEDICAL, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Chief Tech/Sci/R&D Officer Director of Finance/CFO President | |
EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Founder Director/Board Member | |
University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Stanford University | College/University | Doctorate Degree Doctorate Degree | |
New England Eye Center
New England Eye Center Medical/Nursing ServicesHealth Services New England Eye Center offers a full range of ophthalmology services. It specializes in cornea, external disease, and cataracts; glaucoma; oculoplastics; pediatric ophthalmology; retinal and macular diseases; vision rehabilitation; uveitis and immunology; pediatric optometry; and vision correction surgery. The company is headquartered in Boston, MA. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal | |
CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
American Academy of Ophthalmology, Inc.
American Academy of Ophthalmology, Inc. Miscellaneous Commercial ServicesCommercial Services American Academy of Ophthalmology, Inc. is the world's largest association of eye physicians and surgeons. The non-profit company is based in San Francisco, CA, and has subsidiaries in the United States. The company advocates for patients and the public and set standards for ophthalmic education. The organization provides information about managing a practice, clinical pearls, and how to thrive in residency for young ophthalmologists. The company also offers an Outstanding Humanitarian Service Award and have committees that are essential to the establishment and implementation of the organization's mission and strategic goals. The Academy's website, EyeSmart, provides information on eye diseases, treatments, news, and tips for lifelong eye health. The company also has a faculty development program for their annual meeting and offer a program called Eyecelerator that advances eye care innovation by connecting creative entrepreneurs with mission-driven investors and access to markets. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Washington University in St. Louis | College/University | Graduate Degree Undergraduate Degree | |
Tufts University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Nacuity Pharmaceuticals, Inc.
Nacuity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nacuity Pharmaceuticals, Inc. develops and markets pharmaceutical products. The company is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The California State University | College/University | Undergraduate Degree Masters Business Admin | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Epiva Biosciences, Inc.
Epiva Biosciences, Inc. BiotechnologyHealth Technology Epiva Biosciences, Inc. develops immunobiotic therapeutics. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member President | |
ALLERGAN PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Director/Board Member | |
OMEGA THERAPEUTICS, INC. | Biotechnology | Founder Founder | |
Ohana Biosciences, Inc.
Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Biotechnology | Founder Founder | |
AXCA HEALPAR | Biotechnology | Founder Founder | |
Epsilon-3 Bio Ltd
Epsilon-3 Bio Ltd Pharmaceuticals: OtherHealth Technology Epsilon-3 Bio Ltd. develops compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders. The company was founded by Martin W. Edwards, Konstantinos Efthymiopoulos, David J. Grainger and Christian De La Tour on June 18, 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Founder Director/Board Member | |
SERES THERAPEUTICS, INC. | Biotechnology | Founder Founder | |
T2 BIOSYSTEMS, INC. | Medical Specialties | Director/Board Member Founder | |
LS Dissolution, Inc.
LS Dissolution, Inc. Chemicals: Major DiversifiedProcess Industries LS Dissolution, Inc. engages in the production of petroleum replacement products and industrial chemicals. It offers chemical and fuel products. The company was founded by George M. Church, Christopher Somerville, Noubar B. Afeyan and Jay D. Keasling in 2005 and is headquartered in South San Francisco, CA. | Chemicals: Major Diversified | Founder Founder | |
University of California, Irvine | College/University | Doctorate Degree Corporate Officer/Principal | |
Novo Ventures 1 A/S
Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Investor Relations Contact | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree Masters Business Admin | |
Edimer Pharmaceuticals, Inc.
Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
Vereinigte Staaten | 43 |
Schweiz | 3 |
Kanada | 3 |
Vereinigtes Königreich | 3 |
Irland | 2 |
Sektoral
Health Technology | 32 |
Consumer Services | 10 |
Finance | 5 |
Commercial Services | 4 |
Process Industries | 3 |
Operativ
Director/Board Member | 297 |
Corporate Officer/Principal | 140 |
Founder | 70 |
Independent Dir/Board Member | 69 |
Chairman | 57 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Noubar Afeyan | 76 |
Martin Edwards | 38 |
David Berry | 31 |
Nanna Liebach Lüneborg | 29 |
Mark Levin | 26 |
Julie McHugh | 26 |
Wendy Dixon | 25 |
David Gryska | 20 |
Cameron Wheeler | 20 |
Peter John McDonnell | 19 |
David Endicott | 18 |
Cary Pfeffer | 18 |
Richard Gaster | 17 |
Stephen Allen Hurly | 16 |
Gregory Perry | 16 |
- Börse
- Insiders
- Gary Jay Sternberg
- Unternehmensverbindungen